Form4insider filings, from the source

SEC Form 4 · accession 0000921895-18-002113

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Jul 9, 2018
Accepted (ET)
Jul 16, 2018 · 5:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 9, 2018J1,135,768$0.00A1,182,932D
Common StockF1,F4Jul 9, 2018J2,972,592$0.00D0IBy: Lone Star Value Investors, LP
9.00% Series A Cumulative Preferred StockF1,F4Jul 9, 2018J405,395$0.00D0IBy: Lone Star Value Investors, LP
9.00% Series A Cumulative Preferred StockF1Jul 9, 2018J154,893$0.00A154,893D
Common StockF1,F7holding———13,910IBy: Lone Star Value Co-Invest I, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses